publication venue for
- Predicting Treatment Effects of a New-to-Market Drug in Clinical Practice Based on Phase III Randomized Trial Results.. 114:853-861. 2023
- Diversity in Clinical Pharmacology: A Call to Action.. 113:483-485. 2023
- Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney Disease.. 112:1098-1107. 2022
- Cannabis for Medical Use: Clinical Pharmacology Perspectives on Scientific and Regulatory Challenges.. 111:732-735. 2021
- Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease.. 109:1631-1638. 2021
- Association of Pharmacogenetic Markers With Atazanavir Exposure in HIV-Infected Women.. 107:315-318. 2019
- The ImPreSS Trial: Implementation of Point-of-Care Pharmacogenomic Decision Support in Perioperative Care.. 106:1179-1183. 2019
- Generic Drugs in the United States: Policies to Address Pricing and Competition.. 105:329-337. 2019
- Factors Associated With Postmarketing Research for Approved Indications for Novel Medicines Approved by Both the FDA and EMA Between 2005 and 2010: A Multivariable Analysis.. 104:1000-1007. 2018
- Two Case Studies on How Study Designs Can Be Made More Informative Using Modeling and Simulation Approaches.. 102:908-911. 2017
- Associations of High-Dose Melphalan Pharmacokinetics and Outcomes in the Setting of a Randomized Cryotherapy Trial.. 102:511-519. 2017
- Successful Comparison of US Food and Drug Administration Sentinel Analysis Tools to Traditional Approaches in Quantifying a Known Drug-Adverse Event Association.. 100:558-564. 2016
- Current thinking on the mechanistic basis of Alzheimer's and implications for drug development.. 98:469-71. 2015
- Benzodiazepine use and cognitive function among community-dwelling elderly.. 64:684-92. 1998